The human immunodeficiency virus (HIV) causes persistent infection and chronic progressive disease involving multiple organ systems but the pathogenesis of the lesions is not understood. Development of lesions correlates with a high degree of virus gene expression of macrophages in pathologically affected tissues. Among non-human primates, different species of African monkeys are naturally infected with indigenous lentiviruses, but these agents are apathogenic in these animals. However, inoculation of Asian macaques with the viruses results in disease that resembles the HIV disease complex. Lesions in diseased macaque tissues are accompanied by extensive virus replication in tissue macrophages, similar to that seen in human tissues. In this application, we ask if there are cell-culture correlates that can predict pathogenicity of these viruses. Our central hypothesis is that host macrophages, in addition to T4 lymphocytes, must be susceptible to productive replication of viruses that cause disease. This predicts that host species of animals that do not develop disease will have T4 lymphocytes permissive for virus replication but macrophages will be non- permissive. On the other hand, species that do develop disease will have permissive lymphocytes and permissive macrophages. We will test the hypothesis in established model systems of apathogenic infection in African monkeys and fulminant disease in macaques. Lymphocytes and macrophages from uninfected animals will be tested for permissiveness of virus replication and similar cells from infected animals will be examined for evidence of productive virus replication. Multiple parameters of infection in the cell cultures will include tests for viral RNA, viral proteins, virions, and virus infectivity. We will then use this strategy to test permissiveness of cells of different macaque species to infection with lentiviruses of unknown pathogenicity. Fully permissive systems will be tested for confirmation of pathogenicity in limited experiments in macaques at the Yerkes Primate Center. The project will combine expertise in lentivirus-macrophage biology, ultrastructural analysis and existing expertise of lentivirus pathogenesis in macaques at the Yerkes Primate Center and access to exotic species of non-human primates. These experiments will provide a valuable, relatively inexpensive test system for identification of new models of AIDS and contribute to the further understanding of lentivirus disease.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Research Project (R01)
Project #
5R01RR006753-02
Application #
3421696
Study Section
Animal Resources Review Committee (AR)
Project Start
1991-09-01
Project End
1993-01-31
Budget Start
1992-09-01
Budget End
1993-01-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Kumar, Anil; Liu, Zhenqian; Sheffer, Darlene et al. (2008) Protection of macaques against AIDS with a live attenuated SHIV vaccine is of finite duration. Virology 371:238-45
Liu, ZhenQian; Singh, Dinesh K; Sheffer, Darlene et al. (2006) Immunoprophylaxis against AIDS in macaques with a lentiviral DNA vaccine. Virology 351:444-54
Hegde, Ramakrishna; Liu, ZhenQian; Mackay, Glenn et al. (2005) Antigen expression kinetics and immune responses of mice immunized with noninfectious simian-human immunodeficiency virus DNA. J Virol 79:14688-97
Smith, Marilyn S; Niu, Yafen; Buch, Shilpa et al. (2005) Active simian immunodeficiency virus (strain smmPGm) infection in macaque central nervous system correlates with neurologic disease. J Acquir Immune Defic Syndr 38:518-30
Singh, Dinesh K; Liu, Zhenqian; Sheffer, Darlene et al. (2005) A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS. J Virol 79:3419-28
Mackay, Glenn A; Liu, Zhenqian; Singh, Dinesh K et al. (2004) Protection against late-onset AIDS in macaques prophylactically immunized with a live simian HIV vaccine was dependent on persistence of the vaccine virus. J Immunol 173:4100-7
Kumar, Anil; Mukherjee, Sampa; Shen, Jing et al. (2002) Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus. Virology 301:189-205
Buch, Shilpa J; Villinger, Francois; Pinson, David et al. (2002) Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease. Virology 295:54-62
Smith, Marilyn S; Niu, Yafen; Li, Zhuang et al. (2002) Systemic infection and limited replication of SHIV vaccine virus in brains of macaques inoculated intracerebrally with infectious viral DNA. Virology 301:130-5
Mackay, Glenn A; Niu, Yafen; Liu, Zhen Qian et al. (2002) Presence of Intact vpu and nef genes in nonpathogenic SHIV is essential for acquisition of pathogenicity of this virus by serial passage in macaques. Virology 295:133-46

Showing the most recent 10 out of 52 publications